Suzetrigine: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Suzetrigine. Educational only — not medical advice.

Labeled uses

JOURNAVX is indicated for the treatment of moderate to severe acute pain, including postoperative pain, in adults.

Source: FDA labeling via NIH DailyMed (set f0976da4…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.